Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in Greece.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples